Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
FDC
|
Aarti Pharmalabs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.59 % | 13.66 % | 9.05 % |
|
5yr Avg Net Profit Margin
|
1.67 % | 16.24 % | 8.95 % |
|
Price to Book
|
2.41 | 3.26 | 3.9 |
|
P/E
|
21.51 | 27.65 | 29.14 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | -14.0 Days | 94.46 Days |
|
5yr Average Interest Coverage Ratio
|
6.25 | 90.41 | 12.05 |
|
5yr Avg ROCE
|
6.7 % | 14.95 % | 12.13 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 18.97 % | 15.5 % |
|
5 yr average Debt to Equity
|
0.43 | 0.0 | 0.16 |
|
5yr CAGR Net Profit
|
22.48 % | -2.41 % | n/a |
|
5yr Average Return on Assets
|
1.78 % | 8.73 % | 6.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 69.66 % | 43.72 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.01 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.16 % | -2.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.55 % | 1.1 % | -4.21 % |
|
Akums Drugs & Pharma
|
FDC
|
Aarti Pharmalabs
|
|---|